Wordt geladen...
Polytherapeutic strategies with oncolytic virus–bortezomib and adjuvant NK cells in cancer treatment
Proteasome inhibition and oncolytic virotherapy are two emerging targeted cancer therapies. Bortezomib, a proteasome inhibitor, disrupts the degradation of proteins in the cell leading to accumulation of unfolded proteins inducing apoptosis. On the other hand, oncolytic virotherapy uses genetically...
Bewaard in:
| Gepubliceerd in: | J R Soc Interface |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
The Royal Society
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7879760/ https://ncbi.nlm.nih.gov/pubmed/33402021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1098/rsif.2020.0669 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|